MediCom Oncology
PanoptikumID ec05c610-eb04-539c-abc1-b566a81652ca
Permalink (URI) https://panoptikum.social/ec05c610-eb04-539c-abc1-b566a81652ca
Name MediCom Oncology
Claiming not available

You can only claim personas, if you are logged in.

Engagements, MediCom Oncology has entered
Podcast Role
  MediCom Oncology Clinical Pearls Podcasts author
Gigs, MediCom Oncology has been engaged in
Date Podcast Episode Role
2018-10-26   MediCom Oncology Clinical Pearls Podcasts   Third-generation FLT3 inhibitors in clinical development author
2018-10-05   MediCom Oncology Clinical Pearls Podcasts   Key considerations when prescribing midostaurin with a strong CYP3A4 inhibi author
2018-10-05   MediCom Oncology Clinical Pearls Podcasts   CAR T case study in acute myeloid leukemia author
2018-03-20   MediCom Oncology Clinical Pearls Podcasts   53-year-old woman presenting with severe fatigue and bruising author
2018-03-20   MediCom Oncology Clinical Pearls Podcasts   When to consider iron chelation therapy for a transplant-eligible patient author
2018-03-20   MediCom Oncology Clinical Pearls Podcasts   How to proceed with a patient who presents with idiopathic cytopenia of undetermined significance author
2018-01-05   MediCom Oncology Clinical Pearls Podcasts   Predictors of response to lenalidomide in a non-del(5q) MDS patient author
2018-01-05   MediCom Oncology Clinical Pearls Podcasts   New subcategories of pancreatic cancer allow for a biomarker-driven approach to therapy author
2018-01-05   MediCom Oncology Clinical Pearls Podcasts   What are the unique aspects of pancreas cancer that lead to the development of novel therapeutics? author
2017-12-21   MediCom Oncology Clinical Pearls Podcasts   What are the pros and cons of radiation therapy? author